RELATIONSHIP OF N-DEMETHYLATION OF AMIFLAMINE AND ITS METABOLITE TO DEBRISOQUINE HYDROXYLATION POLYMORPHISM

被引：32

作者：

ALVAN, G ^{[1
]}

GRIND, M ^{[1
]}

GRAFFNER, C ^{[1
]}

SJOQVIST, F ^{[1
]}

机构：

[1] ASTRA LAKEMEDEL AB,RES & DEV,S-15185 SODERTALJE,SWEDEN

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1984年 / 36卷 / 04期

关键词：

D O I：

10.1038/clpt.1984.212

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：515 / 519

页数：5

共 22 条

[1]

ALVAN G, 1982, LANCET, V1, P333

[2]

ALVAN G, 1983, 2ND WORLD C CLIN PHA

[3] NORTRIPTYLINE AND ANTIPYRINE CLEARANCE IN RELATION TO DEBRISOQUINE HYDROXYLATION IN MAN [J].

BERTILSSON, L ;

EICHELBAUM, M ;

MELLSTROM, B ;

SAWE, J ;

SCHULZ, HU ;

SJOQVIST, F .

LIFE SCIENCES, 1980, 27 (18) :1673-1677

[4]

CRANE G E, 1957, Psychiatr Res Rep Am Psychiatr Assoc, V8, P142

[5] THEOPHYLLINE METABOLISM IN RELATION TO ANTIPYRINE, DEBRISOQUINE, AND SPARTEINE METABOLISM [J].

DAHLQVIST, R ;

BERTILSSON, L ;

BIRKETT, DJ ;

EICHELBAUM, M ;

SAWE, J ;

SJOQVIST, F .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1984, 35 (06) :815-821

[6] INFLUENCE OF THE GENETICALLY CONTROLLED DEFICIENCY IN DEBRISOQUINE HYDROXYLATION ON ANTIPYRINE METABOLITE FORMATION [J].

DANHOF, M ;

IDLE, JR ;

TEUNISSEN, MWE ;

SLOAN, TP ;

BREIMER, DD ;

SMITH, RL .

PHARMACOLOGY, 1981, 22 (06) :349-358

[7] DEFECTIVE N-OXIDATION OF SPARTEINE IN MAN - NEW PHARMACOGENETIC DEFECT [J].

EICHELBAUM, M ;

SPANNBRUCKER, N ;

STEINCKE, B ;

DENGLER, HJ .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 16 (03) :183-187

[8] A FAMILY AND POPULATION STUDY OF THE GENETIC-POLYMORPHISM OF DEBRISOQUINE OXIDATION IN A WHITE BRITISH-POPULATION [J].

EVANS, DAP ;

MAHGOUB, A ;

SLOAN, TP ;

IDLE, JR ;

SMITH, RL .

JOURNAL OF MEDICAL GENETICS, 1980, 17 (02) :102-105

[9] SELECTIVE MONOAMINE-OXIDASE INHIBITORS .1. COMPOUNDS RELATED TO 4-AMINOPHENETHYLAMINE [J].

FLORVALL, L ;

ASK, AL ;

OGREN, SO ;

ROSS, SB .

JOURNAL OF MEDICINAL CHEMISTRY, 1978, 21 (01) :56-63

[10]

FOWLER C J, 1982, Drugs of the Future, V7, P501

← 1 2 3 →